Crafting a Cloning Policy


Book Description

Ever since Dolly, the Scottish lamb, tottered on wobbly legs into our consciousness-followed swiftly by other animals: first, mice; then pigs that may provide human transplants, and even an ordinary house cat-thoughts have flown to the cloning of human beings. Legislators rushed to propose a ban on a technique that remains highly hypothetical, although some independent researchers have announced their determination to pursue the possibilities. Political scientist and well-known expert on reproductive issues, Andrea L. Bonnicksen examines the political reaction to this new-born science and the efforts to construct cloning policy. She also looks at issues that relate to stem cell research, its even newer sibling, and poses a key question: How does the response to Dolly guide us as we manage innovative reproductive technologies in the future? Various legislative endeavors and the efforts by the Food and Drug Administration (FDA) to oversee cloning, as well as policy models related to federal funding, individual state laws, and programs abroad, inform Bonnicksen's identification of four types of cloning policy. She analyzes in depth the roles of diverse interest groups as each struggle to become the dominant voice in the decision-making process. With skill and insight, she clears the mists from a complicated topic, and addresses the legal, political, and ethical arguments that are not likely to disappear from the national conversation or debates any time soon.




Crafting A Cloning Policy


Book Description

Ever since Dolly, the Scottish lamb, tottered on wobbly legs into our consciousness -- followed swiftly by other animals: first, mice; then pigs that may provide human transplants, and even an ordinary house cat -- thoughts have flown to the cloning of human beings. Legislators rushed to propose a ban on a technique that remains highly hypothetical, although some independent researchers have announced their determination to pursue the possibilities.Political scientist and well-known expert on reproductive issues, Andrea L. Bonnicksen examines the political reaction to this new-born science and the efforts to construct cloning policy. She also looks at issues that relate to stem cell research, its even newer sibling, and poses a key question: how does the response to Dolly guide us as we manage innovative reproductive technologies in the future?Various legislative endeavors and the efforts by the Food and Drug Administration (FDA) to oversee cloning, as well as policy models related to federal funding, individual state laws, and programs abroad, inform Bonnicksen's identification of four types of cloning policy. She analyzes in depth the roles of diverse interest groups as each struggle to become the dominant voice in the decision-making process. With skill and insight, she clears the mists from a complicated topic, and addresses the legal, political, and ethical arguments that are not likely to disappear from the national conversation or debates any time soon.




Human Cloning


Book Description

From this collection, readers will gain a clearer picture of the history of cloning in agriculture and animal science, the various biological procedures that are encompassed by the term "cloning," the philosophical arguments in support of and opposed to cloning humans, and the considerations that should inform discussions about public policy matters related to cloning research and to human cloning itself.




The Cloning Sourcebook


Book Description

Animal cloning has developed quickly since the birth of Dolly the sheep. Yet many of the first questions to be raised still need to be answered. What do Dolly and her fellow mouse, cow, pig, goat and monkey clones mean for science? And for society? Why do so many people respond so fearfully to cloning? What are the ethical issues raised by cloning animals, and in the future, humans? How are the makers of public policy coping with the stunning fact that an entire animal can be reconstructed from a single adult cell? And that humans might well be next? The Cloning Source Book addresses all of these questions in a way that is unique in the cloning literature, by grounding what is effectively an interdisciplinary conversation in solid science. In the first section of the book, the key scientists responsible for the early and crucial developments in cloning speak to us directly, and other scientists evaluate and comment on these developments. The second section explores the context of cloning and includes sociological, mythological, and historical perspectives on science, ethics, and policy. The authors also examine the media's treatment of the Dolly story and its aftermath, both in the United States and in Britain. The third section, on ethics, contains a broad range of papers written by some of the major commentators in the field. The fourth section addresses legal and policy issues. It features individual and collective contributions by those who have actually shaped public policy on reproductive cloning, therapeutic cloning, and similarly contentious bioethical issues in the United States, Britain, and the European Union. Animal cloning continues for agricultural and medicinal purposes, the latter in combination with transgenics. Human cloning for therapeutic purposes has recently been made legal in Britain. The goal is to produce an early embryo and then derive stem cells that are immunologically matched to the donor. Two human reproductive cloning projects have been announced, and there are almost certainly others about which we know nothing. Sooner or later a cloned human will be born. Many lessons can be learned from the cloning experience. Most importantly, there needs to be a public conversation about the permissible uses of new and morally murky technologies. Scientists, journalists, ethicists and policy makers all have roles to play, but cutting-edge science is everybody's business. The Cloning Sourcebook provides the tools required for us to participate in shaping our own futures.




Human Cloning


Book Description




Cloning


Book Description

In this comprehensive introduction, biologist Aaron Levine provides a thorough exploration of the science and ethics of cloning.




Cloning


Book Description

Would you drink milk from a cloned cow? Should we clone extinct or endangered species? Are we justified in using stem cells to develop cures? When will we clone the first human? Ever since Dolly the sheep, such questions have rarely been far from the public consciousness. Aaron Levine explains the science of cloning and guides readers around the thorny political and ethical issues that have developed.




Human Cloning


Book Description




Chimeras, Hybrids, and Interspecies Research


Book Description

In his 2006 State of the Union speech, President George W. Bush asked the U.S. Congress to prohibit the "most egregious abuses of medical research," such as the "creation of animal–human hybrids." The president's message echoed that of a 2004 report by the President's Council on Bioethics, which recommended that hybrid human–animal embryos be banned by Congress. Discussions of early interspecies research, in which cells or DNA are interchanged between humans and nonhumans at early stages of development, can often devolve into sweeping statements, colorful imagery, and confusing policy. Although today's policy advisory groups are becoming more informed, debate is still limited by the interchangeable use of terms such as chimeras and hybrids, a tendency to treat all forms of interspecies alike, the failure to distinguish between laboratory research and procreation, and not enough serious policy justification. Andrea Bonnicksen seeks to understand reasons behind support of and disdain for interspecies research in such areas as chimerism, hybridization, interspecies nuclear transfer, cross-species embryo transfer, and transgenics. She highlights two claims critics make against early interspecies studies: that the research will violate human dignity and that it can lead to procreation. Are these claims sufficient to justify restrictive policy? Bonnicksen carefully illustrates the challenges of making policy for sensitive and often sensationalized research—research that touches deep-seated values and that probes the boundary between human and nonhuman animals.




Biotechnology Policy across National Boundaries


Book Description

A globalization of innovation has produced the most massive spurt in biotechnology in world history. Businesses, universities, and non-governmental organizations are collaborating to produce a "science-industrial complex" in biotechnology. Using case studies of stem cell research, cloning, genetically modified food, in-vitro fertilization, and chimeras in a number of Eastern and Western countries around the world, I argue that much of this biotech activity is global in nature and independent of state control. This shift in the relative influence of state and non-state actors has led to the virtual deregulation of biotechnology and the liberation of innovation from geo-political constraints. These trends post a number of interesting social, political, and ethical issues for the contemporary period and suggest the need to rethink how controversial moral issues are handled by the science-industrial complex.